-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FoeKQfFUJsNyKjg+kNs3wsFBQaMETsyOOQ/Y0NPH+tKwpYdYSxaahbVFGarfV6iI uWX5FNsr19wm9dEdz0wfiw== /in/edgar/work/20000908/0000950123-00-008388/0000950123-00-008388.txt : 20000922 0000950123-00-008388.hdr.sgml : 20000922 ACCESSION NUMBER: 0000950123-00-008388 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000830 FILED AS OF DATE: 20000908 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SYBRON CHEMICALS INC CENTRAL INDEX KEY: 0000832815 STANDARD INDUSTRIAL CLASSIFICATION: [2890 ] IRS NUMBER: 510301280 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 001-12263 FILM NUMBER: 719145 BUSINESS ADDRESS: STREET 1: BIRMINGHAM RD STREET 2: PO BOX 66 CITY: BIRMINGHAM STATE: NJ ZIP: 08011 BUSINESS PHONE: 6098931100 MAIL ADDRESS: STREET 1: P O BOX 66 BIRMINGHAM ROAD CITY: BIRMINGHAM STATE: NJ ZIP: 08011 COMPANY DATA: COMPANY CONFORMED NAME: BAYER CORP CENTRAL INDEX KEY: 0001008007 STANDARD INDUSTRIAL CLASSIFICATION: [ ]OWNER IRS NUMBER: 251339219 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 100 BAYER ROAD CITY: PITTSBURGH STATE: PA ZIP: 152059741 BUSINESS PHONE: 4127772000 MAIL ADDRESS: STREET 1: 100 BAYER ROAD CITY: PITTSBURGH STATE: PA ZIP: 15209 3 1 y399854e3.txt FORM 3 1 - -------- FORM 3 - -------- U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 - ----------------------------------------------------------------------------------------------------------------------------------- 1. Name and Address of Reporting Person 2. Date of Event Requiring 4. Issuer Name and Ticker or Statement Trading Symbol - ---------------------------------------- (Month/Day/Year) Sybron Chemicals Inc. (AMEX:SYC) (Last) (First) (Middle) 8/30/00 ----------------------------------------------------------- ---------------------------- 5. Relationship of Reporting 6. If Amendment, Date Bayer Corporation 3. IRS or Social Security Person to Issuer of Original - ---------------------------------------- Number of Reporting (Check all applicable) (Month/Day/Year) (Street) Person (Voluntary) X 7. Individual or Joint/ ----- Director ----- 10% Owner Group Filing (Check 100 Bayer Road ---------------------------- Applicable Line) - ---------------------------------------- ----- Officer ----- Other (specify (City) (State) (Zip) (give title below) below) -- Form filed by One President Reporting Person Pittsburgh PA 15205 --------------------------- X -- Form filed by More than One Reporting Person - ----------------------------------------------------------------------------------------------------------------------------------- TABLE I -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED - ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Security 2. Amount of Securities 3. Ownership Form: 4. Nature of Indirect (Instr. 4) Beneficially Owned Direct (D) or Beneficial (Instr. 4) Indirect (I) Ownership (Instr. 5) (Instr. 5) - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock, par value $.01 per share 0(1) N/A - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 5(b)(v). - -------------- (1) See note 1 on page 2.
2 FORM 3 (CONTINUED) TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
- ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Derivative Security 2. Date 3. Title and Amount of 4. Conver- 5. Owner- 6. Nature of Indirect (Instr. 4) Exercisable and Securities Underlying sion or ship Beneficial Ownership Expiration Date Derivative Security Exercise Form of (Instr. 5) (Month/Day/ (Instr. 4) Price of Deriv- Year) Deri- ative vative Security: Security Direct (D) ------------------------------------------------- or Date Expira- Amount or Indirect (I) Exercis- tion Title Number (Instr. 5) able Date of Shares - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: (1) On August 30, 2000, Bayer Corporation, an Indiana corporation and a wholly owned subsidiary of Bayer Aktiengesellschaft ("Parent"), and Project Toledo Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (the "Purchaser"), entered into a Stockholder Agreement (the "Stockholder Agreement") with 399 Venture Partners, Inc., Richard M. Klein and John H. Schroeder (each a "Stockholder" and, collectively the "Stockholders") pursuant to which each Stockholder has agreed, among other things, to tender the Shares (as defined below) owned by such Stockholder into the Purchaser's offer to purchase all the outstanding shares of common stock, par value $.01 per share (the "Shares"), of Sybron Chemicals Inc., a Delaware corporation (the "Company"), together with the associated rights to purchase Series A Junior Participating Preferred Stock pursuant to the rights agreement by and between the Company and Fleet National Bank, as rights agent, as amended as of August 30, 2000. Under the Stockholder Agreement, each Stockholder has granted to certain individuals designated by Parent an irrevocable proxy with respect to the Shares subject to the Stockholder Agreement to vote such Shares under certain circumstances. See Joint Filer Information on attached page. **Intentional misstatements or omissions of facts constitute Federal Criminal /s/ E.L. Foote, Jr. September 8, 2000 Violations. ------------------------------- ----------------- See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Name: E.L. Foote, Jr. Date Title: Executive Vice President Note: File three copies of this Form, one of which must be manually signed. **Signature of Reporting Person If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Page 2 of 3 pages 3 JOINT FILER INFORMATION Title of Securities: Common Stock, par value $0.01 per share Issuer & Ticker Symbol: Sybron Chemicals Inc. (SYC) Designated Filer: Bayer Corporation Other Joint Filers: Project Toledo Acquisition Corp. 100 Bayer Road Pittsburgh, PA 15205-9741 Bayer Aktiengesellschaft D-51368 Leverkusen Germany Date of Event Requiring Statement: August 30, 2000 PROJECT TOLEDO ACQUISITION CORP., by /s/ John L. Williams ------------------------------ Name: John L. Williams Title: President BAYER AKTIENGESELLSCHAFT, by /s/ Roland Hartwig ------------------------------ Name: Dr. Roland Hartwig Title: General Counsel Page 3 of 3 pages -----END PRIVACY-ENHANCED MESSAGE-----